The global cannula market size was estimated at USD 204.22 million in 2025 and is anticipated to grow from USD 218.69 million in 2026 till USD 388.52 million in 2034, growing at a CAGR of 7.45% from 2026 to 2034. Growth is fueled by the increasing incidence of chronic diseases, coupled with more hospital and outpatient procedures, and the accelerated adoption of minimally invasive surgeries.
Download a Free Sample to Explore Detailed Market Insights
Source: Straits Research Analysis
Cannulas are integral in intravenous therapies, fluid management, and drug administration, making them essential in both routine and critical care.
In addition, the growing demand for home healthcare solutions has boosted the use of cannulas for long-term therapies, particularly in elderly and chronic care patients. Continuous product innovations, including safety-engineered cannulas that reduce the risk of needlestick injuries and smart cannulas with integrated monitoring features, are further enhancing procedural efficiency and patient outcomes.
With hospitals, clinics, and home care providers emphasizing patient safety, infection prevention, and workflow optimization, manufacturers are increasingly focusing on developing multi-functional, portable, and user-friendly cannulation devices. These factors collectively position the global cannula market for sustained expansion over the coming years.
Manufacturers are transitioning from the standard cannulas to safety-engineered products that reduce the needlestick injuries and blood exposure, which further drives the market growth.
Such innovation drives the growth by enabling manufacturers to command premium pricing, as well as strengthening brand reputation, which thereby expands their presence in the cannula sector.
Cannula applications are moving from conventional manual procedures to integration with robotic-assisted platforms as it improves precision, flexibility and also minimizes tissue damage during the surgeries.
Such innovations boost the demand for specialized cannulas in robotic-assisted surgeries, which further fuels the market growth.
Rising adoption of cannulas for home healthcare drives the market growth as patients, especially the elderly, increasingly seek safe, portable, as easy-to-use cannulas for at-home intravenous therapy. Such a factor encourages manufacturers to develop home care-friendly, safe and easy-to-use products, which boosts overall growth.
Supportive government policies are focusing towards improving access to raw materials, which further fuels the growth of cannula sector.
Such factor reduces production delays, lowers costs, and ensures consistent manufacturing across various gauge sizes, which collectively drives the overall market growth.
The cannulation market faces significant procedural challenges, that restrain the market growth as it includes high failure rates and repeated insertion attempts.
This challenge not only hampers cannula adoption but also drives the use of substitute products, thus hampering the sector’s growth.
A key opportunity in the cannula market is the expansion of local manufacturing to meet the growing demand for IV cannulas.
Such factor strengthens the domestic production capabilities by focusing on the rising demand for IV cannula, hence expanding the market growth.
The intravenous cannula segment dominated the market with a revenue share of 36.53% in 2025. The growth is attributed to rapid as well as efficient routes of administering fluids into the bloodstream, and its frequent use in chemotherapy, dialysis as well as both pre and post-surgical care.
The oxygen delivery segment is anticipated to grow at a CAGR of 8.21% during 2026 - 2034. This growth is attributed to the rising prevalence of chronic respiratory diseases, such as COPD as well as asthma, age-related breathing difficulties, and the growing demand for supplemental oxygen therapy in both hospital as well as home care settings.
The 18G segment dominated the market in 2025. This growth is attributed to the wide preference of 18G sizes in hospitals for the balance between the flow rate and patient comfort. In addition, they are commonly used for administering IV fluids, blood transfusions and medications in both emergency as well as routine care.
The plastic segment dominated the market in 2025. The growth is attributed to ease of manufacturing across multiple gauges, compatibility with advanced IV systems, flexibility for patient comfort, and the ability to integrate with safety-engineered features.
The hospitals and clinics segment dominated the market in 2025 with a revenue share of 55%. This growth is attributed to the hospitals handling the largest volume of patients that require intravenous therapy, surgeries, oxygen delivery as well as blood transfusions, in which most of them rely on the cannulas.
The North America region dominated the market with a revenue share of 41.02% in 2025. The growth is attributed to factors such as high surgical volumes, chronic disease-related infusion therapies, adoption of safety cannulas under strict regulations, and the strong presence of leading manufacturers.
The Asia Pacific region is the fastest-growing region with a CAGR of 8.92% during the forecast timeframe. The growth is attributed to factors such as a rapidly expanding population base, government initiatives to strengthen the healthcare infrastructure as well as the presence of domestic manufacturing hubs that support the wider accessibility of cannulas.
The global cannula market is highly fragmented in nature due to the presence of numerous international, regional as well as local players offering diverse product portfolios at competitive pricing. The top players are Medtronic, BD, Edwards Lifesciences Corporation, LivaNova PLC, United Medical Supply and Others.
The industry participants are inclined towards adopting key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a strong foothold in the market.
ClearPoint Neuro, Inc. is a device, cell as well as gene therapy enabling company that offers precise navigation to the brain as well as spine.
The global cannula market is fueling due to the rising demand for minimally invasive procedures, driving adoption in surgical, cardiovascular as well as aesthetic applications. The increasing prevalence of chronic diseases requires intravenous therapy and critical care, which further fuels the market demand. Moreover, supportive regulatory approvals as well as expansion of healthcare infrastructure across the emerging economies are facilitating wider product penetration, which further expands the market growth. Collectively, all these factors combined boost the adoption, improve the treatment outcomes and also strengthen the global medical device ecosystem for the cannula applications.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com